Investor
The nine-figure deal is set to close before the midpoint of 2021.
The deal has brought the consumer telehealth and wellness company approximately $280 million in proceeds that it will use to grow and invest in new product categories.
Kenzen’s wearable device is designed to keep frontline workers in hazardous environments safe by monitoring users' health metrics.
The company plans to use the funds to continue to develop its platform and expand nationally.
Royal Philips purchased the company for $635 million from a PE firm.
The New York-based company also announced the launch of a pediatric care offering for children ages 3-17.
The automated care platform has been deployed at several health systems to remotely monitor, analyze and communicate with patients across a range of conditions.
Also: NeuroFlow's $20 million Series B, and the launch of two new health tech investment funds.
Avhana's platform is able to integrate into provider's EHRs and suggest treatments, including digital.
The companies' $2.1 billion deal was announced in late 2019, but delayed by regulatory concerns.